Hypera S.A.
HYPE3
Rank in Stocks
#4245
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
Share Price
$5.33
Market Cap
$3.75B
Change (1 day)
2.16%
Change (1 year)
25.26%
Country
BR
Trade Hypera S.A. (HYPE3)
Category
Healthcare
Stock price history for Hypera S.A. (HYPE3)
Highest end of day price: $5.03 on 2026-10-01
Lowest end of day price: $4.81 on 2008-04-01
Lowest end of day price: $4.81 on 2008-04-01
Stock price history of Hypera S.A. from 2008 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -0.71% |
| 2025 | 45.17% |
| 2024 | -58.10% |
| 2023 | -12.37% |
| 2022 | 62.46% |
| 2021 | -21.43% |
| 2020 | -22.43% |
| 2019 | 1.82% |
| 2018 | -25.66% |
| 2017 | 46.20% |
| 2016 | 28.75% |
| 2015 | -6.93% |
| 2014 | -19.33% |
| 2013 | 0.07% |
| 2012 | 62.59% |
| 2011 | -67.38% |
| 2010 | 28.81% |
| 2009 | 327.96% |
| 2008 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
